5. 95
HKD +0.61
+11.319%
2.54B Market Cap
- P/E Ratio
- Div Yield
20.06M Volume
- Eps
5.34 HKD
Previous Close Want to track 2616 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CStone Pharmaceuticals (2616) Statistics
Valuation metrics
Market Cap 2.54B
Enterprise value 6.81B
Trailing P/E (ttm) -21.49
Forward P/E -
PEG ratio 0.16
Price/Sales (ttm) 29.46
Price/Book (mrq) 10.7
Enterprise Value/Revenue 27.8
Enterprise Value/EBITDA -25.6
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.6M
Average volume (90 days) 9.34M
Price summary
52-Week low 4.01
52-Week high 13.15
Beta -
50-Day moving average 4.81
200-Day moving average 6.51
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.23%
Operating margin -1.2%
Operational effectiveness
Return on assets -0.22%
Return on equity -0.65%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.17
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.21
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.63
Total debt (mrq) -
Total Debt/Equity (mrq) 0.57
Current ratio (mrq) 2.18%
Book value per share (mrq) 0.42
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
